IV Heparin Preoperatively
For most elective surgeries, IV heparin should NOT be administered preoperatively as routine practice; instead, low-dose subcutaneous heparin (5,000 units) given 2 hours before surgery is the standard prophylactic approach for VTE prevention. 1
When IV Heparin IS Indicated Preoperatively
IV heparin is specifically indicated preoperatively only in these situations:
1. Cardiovascular Surgery
- Patients undergoing open-heart surgery with cardiopulmonary bypass require an initial bolus of at least 150 units/kg 1
- For procedures <60 minutes: 300 units/kg
- For procedures >60 minutes: 400 units/kg
- This is administered at the time of surgery, not hours before
2. Bridging Anticoagulation (High Thrombotic Risk Patients)
When patients on chronic anticoagulation require surgery and are at high risk for arterial thromboembolism:
IV UFH Bridging Protocol:
- Stop IV heparin infusion 4-6 hours before surgery 2
- Target aPTT 1.5-2.0 times control preoperatively
- Resume postoperatively without bolus at same infusion rate when hemostasis adequate 3
- IV UFH is preferred over LMWH only in patients with severe renal insufficiency or dialysis-dependence 3, 2
Standard VTE Prophylaxis (NOT IV Heparin)
The FDA-approved and guideline-recommended approach for routine surgical VTE prophylaxis is:
- 5,000 units subcutaneous heparin given 2 hours before surgery
- Continue 5,000 units every 8-12 hours postoperatively for 7 days or until fully ambulatory 1
- Administer via deep subcutaneous injection (above iliac crest or abdominal fat layer) with 25-26 gauge needle
Critical Timing Considerations
Preoperative heparin timing matters significantly:
- Starting heparin 1-10 hours before incision provides >2-fold reduction in thromboembolism 4
- Starting >10 hours before incision shows no protective effect 4
- Avoid intramuscular administration due to high hematoma risk 1
When to Avoid IV Heparin
Do NOT use routine IV heparin for:
- Standard elective surgeries (use subcutaneous prophylaxis instead)
- Patients without high thrombotic risk requiring bridging
- Initial VTE treatment (LMWH or DOACs are superior) 5
Common Pitfalls
- Confusing therapeutic IV heparin with prophylactic dosing - Most surgeries only need low-dose subcutaneous prophylaxis
- Using IV UFH when LMWH is appropriate - LMWH provides more predictable anticoagulation with less monitoring 5
- Stopping IV heparin too close to surgery - Must allow 4-6 hours for elimination (half-life 30-120 minutes) 2
- Resuming therapeutic heparin too early postoperatively - Wait for adequate surgical hemostasis to avoid reoperation for bleeding 3
Monitoring Requirements
When IV heparin is used:
- Baseline: aPTT, INR, platelet count 1
- During continuous infusion: aPTT every 4 hours initially 1
- Target aPTT: 1.5-2 times control (or 60-85 seconds in pediatrics) 1
- Monitor platelets, hematocrit, and stool occult blood throughout therapy 1
The 2022 CHEST guidelines emphasize that bridging with therapeutic-dose heparin should be administered to minimize bleeding risk, with postoperative resumption only when adequate hemostasis is achieved 3. The flexibility in timing postoperative resumption is critical since peak anticoagulant effect occurs within 2-4 hours of administration.